Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sulodexide for the Prevention of Recurrent Venous Thromboembolism: The Sulodexide in Secondary Prevention of Recurrent Deep Vein Thrombosis (SURVET) Study: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.
Andreozzi GM, Bignamini AA, Davì G, Palareti G, Matuška J, Holý M, Pawlaczyk-Gabriel K, Džupina A, Sokurenko GY, Didenko YP, Andrei LD, Lessiani G, Visonà A; SURVET Study Investigators. Andreozzi GM, et al. Among authors: sokurenko gy. Circulation. 2015 Nov 17;132(20):1891-7. doi: 10.1161/CIRCULATIONAHA.115.016930. Epub 2015 Sep 25. Circulation. 2015. PMID: 26408273 Free PMC article. Clinical Trial.
Unprovoked or provoked venous thromboembolism: not the prevalent criterion to decide on anticoagulation extension in clinical practice of various countries-the prospective, international, observational WHITE study.
Palareti G, Bignamini A, Cini M, Li YJ, Urbanek T, Madaric J, Bouslama K, Sokurenko GY, Andreozzi GM, Matuška J, Mansilha A, Barinov V; WHITE study group. Palareti G, et al. Among authors: sokurenko gy. Intern Emerg Med. 2022 Jan;17(1):71-82. doi: 10.1007/s11739-021-02765-1. Epub 2021 Jul 27. Intern Emerg Med. 2022. PMID: 34313959 Free PMC article.
Anticoagulation Duration After First Venous Thromboembolism: Real-Life Data From the International, Observational WHITE Study.
Palareti G, Bignamini AA, Cini M, Li YJ, Urbanek T, Madaric J, Bouslama K, Sokurenko GY, Andreozzi GM, Matuška J, Mansilha A, Barinov V. Palareti G, et al. Among authors: sokurenko gy. Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211049402. doi: 10.1177/10760296211049402. Clin Appl Thromb Hemost. 2021. PMID: 34841907 Free PMC article.
Influence of clinical presentation, site, and extent of venous thrombosis on decision about duration of anticoagulation: Data from the international, prospective, observational WHITE study.
Palareti G, Bignamini AA, Urbanek T, Cini M, Li YJ, Madaric J, Bouslama K, Sokurenko GY, Andreozzi GM, Matuška J, Mansilha A, Barinov V; WHITE study group. Palareti G, et al. Among authors: sokurenko gy. Thromb Res. 2022 Mar;211:140-146. doi: 10.1016/j.thromres.2022.01.025. Epub 2022 Feb 4. Thromb Res. 2022. PMID: 35151009 Free article.
Recurrences and bleeding during extended treatment of patients with venous thromboembolism: results of the international, prospective, observational WHITE study.
Palareti G, Barinov V, Urbanek T, Cini M, Li YJ, Bouslama K, Matuška J, Mansilha A, Madaric J, Sokurenko GY, Andreozzi GM; WHITE study group. Palareti G, et al. Among authors: sokurenko gy. Int Angiol. 2023 Feb;42(1):37-44. doi: 10.23736/S0392-9590.22.04970-7. Epub 2023 Jan 30. Int Angiol. 2023. PMID: 36714910 Free article.
Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients.
Nissen SE, Lincoff AM, Brennan D, Ray KK, Mason D, Kastelein JJP, Thompson PD, Libby P, Cho L, Plutzky J, Bays HE, Moriarty PM, Menon V, Grobbee DE, Louie MJ, Chen CF, Li N, Bloedon L, Robinson P, Horner M, Sasiela WJ, McCluskey J, Davey D, Fajardo-Campos P, Petrovic P, Fedacko J, Zmuda W, Lukyanov Y, Nicholls SJ; CLEAR Outcomes Investigators. Nissen SE, et al. N Engl J Med. 2023 Apr 13;388(15):1353-1364. doi: 10.1056/NEJMoa2215024. Epub 2023 Mar 4. N Engl J Med. 2023. PMID: 36876740 Clinical Trial.
Fondaparinux for the treatment of superficial-vein thrombosis in the legs.
Decousus H, Prandoni P, Mismetti P, Bauersachs RM, Boda Z, Brenner B, Laporte S, Matyas L, Middeldorp S, Sokurenko G, Leizorovicz A; CALISTO Study Group. Decousus H, et al. N Engl J Med. 2010 Sep 23;363(13):1222-32. doi: 10.1056/NEJMoa0912072. N Engl J Med. 2010. PMID: 20860504 Free article. Clinical Trial.
Stroke in Patients With Peripheral Artery Disease.
Kolls BJ, Sapp S, Rockhold FW, Jordan JD, Dombrowski KE, Fowkes FGR, Mahaffey KW, Berger JS, Katona BG, Blomster JI, Norgren L, Abramson BL, Leiva-Pons JL, Prieto JC, Sokurenko G, Hiatt WR, Jones WS, Patel MR. Kolls BJ, et al. Stroke. 2019 Jun;50(6):1356-1363. doi: 10.1161/STROKEAHA.118.023534. Epub 2019 May 16. Stroke. 2019. PMID: 31092165 Clinical Trial.
Fibrin Sealant TISSEEL Lyo as a haemostatic agent in vascular surgery: Results of randomized, controlled, patient-blinded, multicentre clinical study in the Russian population.
Karpenko AA, Cheban AV, Rabtsun AA, Sokurenko GY, Andreychuk KA, Kim IN, Volf VA, Kuznetsov MR, Prostov II, Sapronova NG, Mzhavanadze ND, Kamaev AA, Suchkov IA. Karpenko AA, et al. Among authors: sokurenko gy. Sci Prog. 2023 Jul-Sep;106(3):368504231182834. doi: 10.1177/00368504231182834. Sci Prog. 2023. PMID: 37427979 Free PMC article. Clinical Trial.
Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE.
Weitz JI, Haas S, Ageno W, Goldhaber SZ, Turpie AGG, Goto S, Angchaisuksiri P, Nielsen JD, Kayani G, Farjat AE, Schellong S, Bounameaux H, Mantovani LG, Prandoni P, Kakkar AK; GARFIELD-VTE investigators. Weitz JI, et al. J Thromb Thrombolysis. 2020 Aug;50(2):267-277. doi: 10.1007/s11239-020-02180-x. J Thromb Thrombolysis. 2020. PMID: 32583306
14 results